An angiogenic gene signature for prediction of the prognosis and therapeutic responses of hepatocellular carcinoma

HIGHLIGHTS

• who: Hongfei Ci et al. from the Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China have published the paper: An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma, in the Journal: (JOURNAL)
• what: The predicting therapy in the model was further evaluated by the DEPMAP database. In this work, the aim is to identify the potential value of angiogenesis-related prognostic genes (ARPGs) in predicting the prognosis and the outcome of HCC patients. The model has an AUC of 0.770, which is significantly higher than the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.